Jane Henderson - Net Worth and Insider Trading

Jane Henderson Net Worth

The estimated net worth of Jane Henderson is at least $11 Million dollars as of 2024-11-05. Jane Henderson is the CFO of Apogee Therapeutics Inc and owns about 200,871 shares of Apogee Therapeutics Inc (APGE) stock worth over $11 Million. Jane Henderson is the Sr. V.P. & CFO, Corp. Dev. of Voyager Therapeutics Inc and owns about 0 shares of Voyager Therapeutics Inc (VYGR) stock worth over $0. Jane Henderson is also the Director of Akero Therapeutics Inc and owns about 0 shares of Akero Therapeutics Inc (AKRO) stock worth over $0. Details can be seen in Jane Henderson's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jane Henderson has not made any transactions after 2024-08-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Jane Henderson

To

Jane Henderson Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jane Henderson owns 7 companies in total, including IVERIC bio Inc (ISEE) , Akero Therapeutics Inc (AKRO) , and Sesen Bio Inc (SESN) among others .

Click here to see the complete history of Jane Henderson’s form 4 insider trades.

Insider Ownership Summary of Jane Henderson

Ticker Comapny Transaction Date Type of Owner
ISEE IVERIC bio Inc 2018-01-13 director
AKRO Akero Therapeutics Inc 2023-06-16 director
SESN Sesen Bio Inc 2014-02-05 director
LIMIT LIMIT 2018-03-23 Sr. V.P. & CFO
LIMIT LIMIT 2021-08-05 Chief Financial Officer
LIMIT LIMIT 2014-02-05 director
LIMIT LIMIT 2024-08-23 Chief Financial Officer

Jane Henderson Latest Holdings Summary

Jane Henderson currently owns a total of 3 stocks. Among these stocks, Jane Henderson owns 200,871 shares of Apogee Therapeutics Inc (APGE) as of August 23, 2024, with a value of $11 Million and a weighting of 100%. Jane Henderson owns 0 shares of Voyager Therapeutics Inc (VYGR) as of March 23, 2018, with a value of $0 and a weighting of 0%. Jane Henderson also owns 0 shares of Akero Therapeutics Inc (AKRO) as of June 16, 2023, with a value of $0 and a weighting of 0%.

Latest Holdings of Jane Henderson

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
APGE Apogee Therapeutics Inc 2024-08-23 200,871 57.16 11,481,786
VYGR Voyager Therapeutics Inc 2018-03-23 0 6.67 0
AKRO Akero Therapeutics Inc 2023-06-16 0 31.78 0

Holding Weightings of Jane Henderson


Jane Henderson Form 4 Trading Tracker

According to the SEC Form 4 filings, Jane Henderson has made a total of 1 transactions in Apogee Therapeutics Inc (APGE) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Apogee Therapeutics Inc is the sale of 6,000 shares on August 23, 2024, which brought Jane Henderson around $289,560.

According to the SEC Form 4 filings, Jane Henderson has made a total of 0 transactions in Voyager Therapeutics Inc (VYGR) over the past 5 years. The most-recent trade in Voyager Therapeutics Inc is the sale of 31,100 shares on March 23, 2018, which brought Jane Henderson around $649,057.

According to the SEC Form 4 filings, Jane Henderson has made a total of 1 transactions in Akero Therapeutics Inc (AKRO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Akero Therapeutics Inc is the sale of 40,000 shares on June 16, 2023, which brought Jane Henderson around $2 Million.

Insider Trading History of Jane Henderson

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jane Henderson Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Jane Henderson Ownership Network

Ownership Network List of Jane Henderson

No Data

Ownership Network Relation of Jane Henderson

Insider Network Chart

Jane Henderson Owned Company Details

What does IVERIC bio Inc do?

Who are the key executives at IVERIC bio Inc?

Jane Henderson is the director of IVERIC bio Inc. Other key executives at IVERIC bio Inc include SVP & COO Keith Westby , SVP & CFO and Treasurer David Francis Carroll , and Senior Vice President & CCO Christopher Paul Simms .

IVERIC bio Inc (ISEE) Insider Trades Summary

Over the past 18 months, Jane Henderson made no insider transaction in IVERIC bio Inc (ISEE). Other recent insider transactions involving IVERIC bio Inc (ISEE) include a net sale of 40,000 shares made by Keith Westby ,

In summary, during the past 3 months, insiders sold 0 shares of IVERIC bio Inc (ISEE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 40,000 shares of IVERIC bio Inc (ISEE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,000 shares.

IVERIC bio Inc (ISEE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

IVERIC bio Inc Insider Transactions

No Available Data

Jane Henderson Mailing Address

Above is the net worth, insider trading, and ownership report for Jane Henderson. You might contact Jane Henderson via mailing address: C/o Eleven Biotherapeutics, Inc., 215 First Street, Cambridge Ma 02142.